DSV’s Cold Chain Logistics: Connecting Key Pharma Hubs

As part of its cold chain logistics operations, DSV has launched a direct air corridor between Luxembourg and Indianapolis, US.

This will be used to move temperature-sensitive pharmaceuticals without active containers.

It expands upon the healthcare capabilities of Indianapolis as one of the fastest growing life sciences hubs in the US.

About the air freight route

DSV has launched the latest expansion of its Air ThermoDirect solution through Indianapolis International Airport.

This aims to strategically strengthen pharmaceutical supply chains with enhanced cold chain connectivity in the US.

AirThermo Direct aims to help pharmaceutical companies protect product integrity while lowering their total cost, emissions and operational uncertainty across critical lanes.

This is done by minimising the time products spend in uncontrolled environments and removing the complexity of active containers.

The connection between Luxembourg and Indianapolis joins together two critical elements of the global pharmaceutical supply chain.

Kenneth Källström, Executive Vice President, Global Head, Healthcare at DSV, says: “The DSV Indianapolis operations will play a pivotal role in the global Air ThermoDirect healthcare network, enhancing end-to-end visibility and control across pharma manufacturing regions in the US, Europe, the Americas and APAC.

“By strengthening these critical supply chain connections, this hub will help ensure that life-saving therapies move with greater speed, reliability and integrity – ultimately delivering better outcomes for patients worldwide.”

The new route creates a cold chain that is predictable and scalable for pharmaceutical companies around the world.

It actively minimises the environmental impact of the pharmaceutical supply chain through optimised handling and more sustainable thermal solutions.

The Indianapolis-Luxembourg route, known as Indy Wings, links two key pharmaceutical gateways, with the Midwestern US attracting strong healthcare investment and demand for pharmaceuticals.

“Indy Wings reflects our strategy to bring the critical points of the supply chain under full accountability, ensuring reliability, integrity and performance where it matters most,” says Stephanie Penarete, Vice President Air Product Americas at DSV.

“With Indy Wings, we continue linking key pharmaceutical hubs with greater precision, resilience and excellence.”

DSV’s cold chain solutions

DSV offers a range of healthcare logistics solutions, with an extensive global network and infrastructure.

It transports sensitive products across the world using active containers and passive packaging, ensuring that the products are stable and kept at the required temperature.

The company provides risk assessments and risk mitigation for all transport lanes, giving full control throughout every link in the cold chain.

DSV offers air, sea or road freight services, managing temperature-controlled cargo at every stage of a product’s journey.

It gives customers real-time monitoring information, including temperature, humidity and other key parameters.

The monitoring platform can provide notifications for any temperature changes throughout the journey and can link to CCTV monitoring systems.

Across its logistics operations, cold chain logistics makes up for 5% of DSV’s volume.

It offers these services for biological specimens, blood plasma, vaccines, animal tissues and Active Pharmaceutical Ingredients (APIs).

As DSV operates its own charter network, warehouses, ocean and road transport providers, it can have full control over the cold chain, reducing reliance on third party logistics providers.

This keeps handover risks at a minimum, creating a more secure pharmaceutical cold chain.